[
  {
    "abstract": "",
    "authors": "",
    "keywords": [],
    "link": "",
    "releaseDate": "",
    "resourceType": "Article",
    "title": "",
    "image": ""
  },
  {
    "abstract": "",
    "authors": "",
    "keywords": [],
    "link": "",
    "releaseDate": "",
    "resourceType": "Article",
    "title": "",
    "image": ""
  },
  {
    "abstract": "Prasad S. Adusumilli, MD, of Memorial Sloan Kettering Cancer Center, discusses phase I/II research he is conducting on CAR T cells delivered intrapleurally in patients with mesothelioma. The treatment is targeting mesothelin, a cancer cell-surface antigen overexpressed in many solid tumors and associated with aggressive disease.",
    "authors": "",
    "keywords": ["Mesothelium"],
    "link": "https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/prasad-adusumilli-on-car-t-cell-therapy-for-mesothelioma/",
    "releaseDate": "Sep 14, 2021",
    "resourceType": "Video",
    "title": "Prasad S. Adusumilli, MD, on CAR T-Cell Therapy for Mesothelioma",
    "image": ""
  },
  {
    "abstract": "Featuring a discussion on advances in the treatment of patients with NSCLC harboring an EGFR exon 20 insertion mutations with Dr Gregory Riely, moderated by Dr Neil Love.",
    "authors": "",
    "keywords": ["NSCLC", "EGFR"],
    "link": "https://podcasts.apple.com/us/podcast/oncology-today-with-dr-neil-love-nsclc-with-egfr-exon/id160270573?i=1000545296478",
    "releaseDate": "Dec 17, 2021",
    "resourceType": "Podcast",
    "title": "Oncology Today with Dr Neil Love: NSCLC with EGFR Exon 20 Insertion Mutations ",
    "image": ""
  }
]